Roche Reports Mixed Results in Trial of an Alzheimer’s Drug
Wednesday, July 16, 2014 - 17:20
in Health & Medicine
While the drug, crenezumab, did not slow progression of the disease over all, at the highest doses it seemed to delay a decline in mental ability in patients with mild Alzheimer’s.